Aug 23, 2025, 15:25
Jason Luke Named New Chief Medical Officer at Strand Therapeutics
Jason Luke, Chief Medical Officer at Strand Therapeutics, shared on X about his career update by Strand Therapeutics, adding:
“Extremely excited for this new opportunity and career challenge!
Strand Therapeutics is a field-leader in RNA engineering, lipid nanoparticle technology, and now clinical cancer immunotherapy.
Our lead program, STX-001, is rapidly advancing with multiple clinical programs coming.
Time to work!”
Quoting Strand Therapeutics‘s post:
“Proud to share that Jason Luke will be joining Strand as Chief Medical Officer!
Previously a professor at UPMC, he brings decades of expertise in cancer immunotherapies to the team.”
More posts featuring Jason Luke on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 23, 2025, 15:25
Aug 23, 2025, 15:21
Aug 23, 2025, 14:56
Aug 23, 2025, 14:52
Aug 23, 2025, 14:36
Aug 23, 2025, 14:11
Aug 23, 2025, 13:51
Aug 23, 2025, 13:38
Aug 23, 2025, 13:32